CN1224391C - 杀内寄生虫组合物 - Google Patents

杀内寄生虫组合物 Download PDF

Info

Publication number
CN1224391C
CN1224391C CNB00807450XA CN00807450A CN1224391C CN 1224391 C CN1224391 C CN 1224391C CN B00807450X A CNB00807450X A CN B00807450XA CN 00807450 A CN00807450 A CN 00807450A CN 1224391 C CN1224391 C CN 1224391C
Authority
CN
China
Prior art keywords
alkyl
butyl
formula
independently represent
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB00807450XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1352559A (zh
Inventor
A·哈德
G·冯萨姆森－希梅尔斯特杰纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7907825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1224391(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1352559A publication Critical patent/CN1352559A/zh
Application granted granted Critical
Publication of CN1224391C publication Critical patent/CN1224391C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CNB00807450XA 1999-05-12 2000-05-04 杀内寄生虫组合物 Expired - Fee Related CN1224391C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19921887.0 1999-05-12
DE19921887A DE19921887A1 (de) 1999-05-12 1999-05-12 Endoparasitizide Mittel

Publications (2)

Publication Number Publication Date
CN1352559A CN1352559A (zh) 2002-06-05
CN1224391C true CN1224391C (zh) 2005-10-26

Family

ID=7907825

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB00807450XA Expired - Fee Related CN1224391C (zh) 1999-05-12 2000-05-04 杀内寄生虫组合物

Country Status (26)

Country Link
EP (1) EP1189615B1 (enExample)
JP (1) JP2002544224A (enExample)
KR (1) KR100704717B1 (enExample)
CN (1) CN1224391C (enExample)
AT (1) ATE258795T1 (enExample)
AU (1) AU768910B2 (enExample)
BR (1) BR0010499A (enExample)
CA (1) CA2373827C (enExample)
CZ (1) CZ300782B6 (enExample)
DE (2) DE19921887A1 (enExample)
DK (1) DK1189615T3 (enExample)
ES (1) ES2211558T3 (enExample)
HK (1) HK1047228B (enExample)
HR (1) HRP20010918B1 (enExample)
HU (1) HUP0201201A3 (enExample)
MX (1) MXPA01011455A (enExample)
NO (1) NO328870B1 (enExample)
PL (1) PL200951B1 (enExample)
PT (1) PT1189615E (enExample)
RS (1) RS50169B (enExample)
RU (1) RU2250779C2 (enExample)
SK (1) SK285494B6 (enExample)
TR (2) TR200103240T2 (enExample)
UA (1) UA72520C2 (enExample)
WO (1) WO2000069425A2 (enExample)
ZA (1) ZA200108238B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
KR101671325B1 (ko) * 2015-01-09 2016-11-02 한국생명공학연구원 신규한 고리형 뎁시펩타이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 항균용 약학적 조성물
US10081656B2 (en) 2015-05-20 2018-09-25 Merial, Inc. Anthelmintic depsipeptide compounds
CA3009867C (en) 2015-12-28 2022-05-31 Merial, Inc. Anthelmintic cyclic depsipeptide compounds
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
US20230339874A1 (en) * 2020-09-11 2023-10-26 The Governing Council Of The University Of Toronto Piperazinyl compounds and methods for treating nematode infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
JPS6471865A (en) * 1987-09-11 1989-03-16 Nichibai Boeki Kk 1-alkylcarbamoyl-4-methylpiperazine derivative
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
EP0718293B1 (en) * 1993-09-06 2002-03-13 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
WO1997009331A1 (en) * 1995-09-07 1997-03-13 Pharmacia & Upjohn Company Cycloanthelmintic inhibitors
WO1998037088A1 (en) * 1997-02-19 1998-08-27 Meiji Seika Kaisha Ltd. Derivatives of cyclodepsipeptide, pf1022 substance
JP2002502398A (ja) * 1997-06-04 2002-01-22 バイエル・アクチエンゲゼルシヤフト デソキシシクロデプシペプチド及び内部寄生性生物の防除のためのその使用
EP1028126A4 (en) * 1998-08-04 2004-11-10 Nisshin Seifun Group Inc DEPSIPEPTIDE DERIVATIVES WITH PIPERAZINE RINGS

Also Published As

Publication number Publication date
EP1189615A2 (de) 2002-03-27
SK285494B6 (sk) 2007-02-01
KR100704717B1 (ko) 2007-04-09
KR20010109527A (ko) 2001-12-10
WO2000069425A3 (de) 2001-03-15
NO20015398D0 (no) 2001-11-05
TR200103240T2 (tr) 2002-04-22
TR200401875T2 (tr) 2005-01-24
SK16262001A3 (sk) 2002-03-05
WO2000069425A2 (de) 2000-11-23
AU5523700A (en) 2000-12-05
CA2373827A1 (en) 2000-11-23
HUP0201201A3 (en) 2003-03-28
AU768910B2 (en) 2004-01-08
ES2211558T3 (es) 2004-07-16
CZ20014060A3 (cs) 2002-06-12
JP2002544224A (ja) 2002-12-24
HRP20010918A2 (en) 2003-04-30
NO20015398L (no) 2001-11-05
CN1352559A (zh) 2002-06-05
YU80501A (sh) 2004-09-03
RS50169B (sr) 2009-05-06
PL200951B1 (pl) 2009-02-27
DK1189615T3 (da) 2004-06-07
NO328870B1 (no) 2010-06-07
DE19921887A1 (de) 2000-11-16
ATE258795T1 (de) 2004-02-15
HRP20010918B1 (en) 2011-01-31
HK1047228A1 (en) 2003-02-14
PL351376A1 (en) 2003-04-07
BR0010499A (pt) 2002-02-13
CZ300782B6 (cs) 2009-08-12
HUP0201201A2 (en) 2002-08-28
MXPA01011455A (es) 2002-07-30
CA2373827C (en) 2008-09-16
RU2250779C2 (ru) 2005-04-27
UA72520C2 (uk) 2005-03-15
PT1189615E (pt) 2004-05-31
EP1189615B1 (de) 2004-02-04
DE50005213D1 (de) 2004-03-11
HK1047228B (zh) 2006-07-21
ZA200108238B (en) 2002-12-24

Similar Documents

Publication Publication Date Title
CN1070481C (zh) 二氧代吗啉类化合物防治体内寄生虫的应用、新的二氧代吗啉类化合物及其制备
CN1142790C (zh) 杀内寄生虫组合物
CN1165338C (zh) 杀体内寄生虫组合物
CN1893919A (zh) 局部施用的杀体内寄生虫组合物
JPH07508723A (ja) 内寄生性生物を駆除するための１８の環原子を有する環状デプシペプチドの利用，１８の環原子を有する新規環状デプシペプチド、ならびにそれらの製造のための方法
CN1195741C (zh) 嘧啶酮化合物,包含该化合物的药物组合物以及制备该化合物的方法
CN1284943A (zh) 含有γ－谷氨酰基和β－天冬氨酰基的免疫调制剂化合物及其制备方法
CN1204921C (zh) 长期稳定溶液制剂
CN1224391C (zh) 杀内寄生虫组合物
CN1196485C (zh) 防治寄生性原生动物的组合物
CN1201456A (zh) 新的环缩肽pf1022物质的衍生物
JP3626233B2 (ja) １２の環原子を有する環状デプシペプチドの内部寄生虫の防除のための利用、１２の環原子を有する新規環状デプシペプチド及びそれらの製造法
CN1306394A (zh) 杀外寄生虫组合物
CN1076349C (zh) 去氧环缩肽及其防治体内寄生虫的用途
CN101080418A (zh) 三肽砜和四肽砜
JP3600287B2 (ja) １８の環原子を有する新規環状デプシペプチド及び内部寄生虫の防除のためのそれらの利用
CN1404397A (zh) 杀体内寄生虫组合物
CN1293664A (zh) 环八缩肽类和其用于防治体内寄生虫的应用
CN1128141C (zh) 1,2,4－三嗪－3,5－二酮衍生物,其制备和用途
JP3798826B2 (ja) 開鎖オクタデプシペプチドに基づく殺内部寄生虫性組成物
JP3798825B2 (ja) 開鎖テトラデプシペプチドに基づく殺内部寄生虫性組成物
JP3798824B2 (ja) 開鎖ヘキサデプシペプチドに基づく殺内部寄生虫性組成物
CN1055473C (zh) 1,9－桥连的噻唑并[3,2－a]喹啉衍生物
CN1325388A (zh) 氮杂环缩肽及其作为杀寄生虫剂的用途
CN1469747A (zh) 三嗪三酮亚砜类在防治球虫病中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BAYER ANIMAL HEALTH PROMOTION CO.,LTD.

Free format text: FORMER OWNER: BAYER AG

Effective date: 20091106

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20091106

Address after: Germany Leverkusen

Patentee after: Bayer Animal Health GmbH

Address before: Germany Leverkusen

Patentee before: Bayer Aktiengesellschaft

ASS Succession or assignment of patent right

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

Free format text: FORMER OWNER: BAYER ANIMAL HEALTH GMBH

Effective date: 20130124

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20130124

Address after: German Monheim

Patentee after: Bayer Pharma Aktiengesellschaft

Address before: Germany Leverkusen

Patentee before: Bayer Animal Health GmbH

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20051026

Termination date: 20140504